Necitumumab and Trastuzumab in Combination With Osimertinib for the Treatment of Refractory Epidermal Growth Factor Receptor (EGFR)-Mutated Stage IV Non-small Cell Lung Cancer
about
Necitumumab and Trastuzumab in Combination With Osimertinib for the Treatment of Refractory Epidermal Growth Factor Receptor (EGFR)-Mutated Stage IV Non-small Cell Lung Cancer
description
clinical trial
@en
name
Necitumumab and Trastuzumab in ...... IV Non-small Cell Lung Cancer
@en
type
label
Necitumumab and Trastuzumab in ...... IV Non-small Cell Lung Cancer
@en
prefLabel
Necitumumab and Trastuzumab in ...... IV Non-small Cell Lung Cancer
@en
P4844
P767
P1050
P1476
UCLA L-08: A Phase Ib/II Study ...... ctory EGFR-Mutated Lung Cancer
@en
P3098
NCT04285671
P580
2020-04-30T00:00:00Z
P582
2022-01-02T00:00:00Z